Mary Beth Chalk

Business Development

Kheiron Medical

About Mary Beth

Mary Beth Chalk has over 25 years of experience in creating, validating, and commercializing digital health solutions. This included her role as a co-founder of an AI platform leveraging device data and social determinants to provide personalized disease management.

In December 2019, Mary Beth was diagnosed with Stage 1 invasive ductal carcinoma after a routine mammogram. Following her lumpectomy in January she underwent 5-days of internal radiation. From screening to the completion of radiation, her cancer journey was 60-days. As her surgeon said, “We have got to get the news out about early stage breast cancer!”